Show more...
Record Information
Version2.0
Created at2022-04-29 04:51:58 UTC
Updated at2022-04-29 04:51:58 UTC
NP-MRD IDNP0083992
Secondary Accession NumbersNone
Natural Product Identification
Common NameEnigmol
DescriptionEnigmol belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Thus, enigmol is considered to be a sphingoid base. Enigmol is found in Averrhoa bilimbi . Enigmol was first documented in 2011 (PMID: 24900327). Based on a literature review a small amount of articles have been published on Enigmol (PMID: 34040925) (PMID: 32737845) (PMID: 27190606) (PMID: 21398423).
Structure
Thumb
Synonyms
ValueSource
2-Amino-3,5-dihydroxyoctadecaneMeSH
Chemical FormulaC18H39NO2
Average Mass301.5150 Da
Monoisotopic Mass301.29808 Da
IUPAC Name(2S,3S,5S)-2-aminooctadecane-3,5-diol
Traditional Nameenigmol
CAS Registry NumberNot Available
SMILES
CCCCCCCCCCCCC[C@H](O)C[C@H](O)[C@H](C)N
InChI Identifier
InChI=1S/C18H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-17(20)15-18(21)16(2)19/h16-18,20-21H,3-15,19H2,1-2H3/t16-,17-,18-/m0/s1
InChI KeyCILLLUONWCSDCK-BZSNNMDCSA-N
Experimental Spectra
Not Available
Predicted Spectra
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Averrhoa bilimbiPlant
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom.
KingdomOrganic compounds
Super ClassOrganic nitrogen compounds
ClassOrganonitrogen compounds
Sub ClassAmines
Direct Parent1,2-aminoalcohols
Alternative Parents
Substituents
  • Secondary alcohol
  • 1,2-aminoalcohol
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Primary amine
  • Organooxygen compound
  • Primary aliphatic amine
  • Alcohol
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP4.88ALOGPS
logP4.36ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)14.45ChemAxon
pKa (Strongest Basic)9.53ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area66.48 ŲChemAxon
Rotatable Bond Count15ChemAxon
Refractivity91.01 m³·mol⁻¹ChemAxon
Polarizability40.36 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00053145
Chemspider ID9590278
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11415391
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Prathiba S, Sabareesh V, Anbalagan M, Jayaraman G: Metabolites from halophilic bacterial isolates Bacillus VITPS16 are cytotoxic against HeLa cells. 3 Biotech. 2021 Jun;11(6):276. doi: 10.1007/s13205-021-02724-9. Epub 2021 May 18. [PubMed:34040925 ]
  2. Soopramanien M, Khan NA, Sagathevan K, Siddiqui R: Gut bacteria of Varanus salvator possess potential antitumour molecules. Int Microbiol. 2021 Jan;24(1):47-56. doi: 10.1007/s10123-020-00139-9. Epub 2020 Jul 31. [PubMed:32737845 ]
  3. Miller EJ, Mays SG, Baillie MT, Howard RB, Culver DG, Saindane M, Pruett ST, Holt JJ, Menaldino DS, Evers TJ, Reddy GP, Arrendale RF, Natchus MG, Petros JA, Liotta DC: Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties. ACS Med Chem Lett. 2016 Mar 21;7(5):537-42. doi: 10.1021/acsmedchemlett.6b00113. eCollection 2016 May 12. [PubMed:27190606 ]
  4. Garnier-Amblard EC, Mays SG, Arrendale RF, Baillie MT, Bushnev AS, Culver DG, Evers TJ, Holt JJ, Howard RB, Liebeskind LS, Menaldino DS, Natchus MG, Petros JA, Ramaraju H, Reddy GP, Liotta DC: Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer. ACS Med Chem Lett. 2011 Mar 25;2(6):438-43. doi: 10.1021/ml2000164. eCollection 2011 Jun 9. [PubMed:24900327 ]
  5. Symolon H, Bushnev A, Peng Q, Ramaraju H, Mays SG, Allegood JC, Pruett ST, Sullards MC, Dillehay DL, Liotta DC, Merrill AH Jr: Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer. Mol Cancer Ther. 2011 Apr;10(4):648-57. doi: 10.1158/1535-7163.MCT-10-0754. Epub 2011 Mar 11. [PubMed:21398423 ]